Form 990 for tax year 2023
Filed by THE STANLEY MEDICAL RESEARCH INSTITUTE.
Totals
- Total revenue
- $4,628,611
- Total expenses
- $6,605,151
- Contributions and grants received
- $13,900
- Grants paid
- $4,604,525
- Program service revenue
- $0
- Investment income
- $4,607,141
- Other revenue
- $7,570
- Total assets, end of year
- $85,710,224
- Total liabilities, end of year
- $221,332
- Net assets or fund balances, end of year
- $85,488,892
- Program services expenses (Part IX)
- $6,223,002
- Management and general expenses
- $382,149
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $6,223,002
Program services were 94.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$13,900
-
3 · Investment income
total $1,634,512 · excluded $1,634,512
-
5 · Royalties
total $6,051 · excluded $6,051
-
7a · Gross sales of assets other than inventory
securities $5,748,000
-
7b · Less cost or other basis and sales expenses
securities $2,775,371
-
7c · Gain or loss
securities $2,972,629
-
7d · Net gain or loss
total $2,972,629 · excluded $2,972,629
-
11a · Other revenue: GRANT REFUNDS
total $1,299 · excluded $1,299
-
11b · Other revenue: OTHER
total $220 · excluded $220
-
11e · Other revenue, total
$1,519
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $3,826,770 · program services $3,826,770
-
3 · Grants to foreign organizations and individuals
total $777,755 · program services $777,755
-
5 · Compensation of officers, directors and key employees
total $328,169 · program services $245,977 · management and general $82,192
-
7 · Other salaries and wages
total $567,121 · program services $418,951 · management and general $148,170
-
8 · Pension plan contributions
total $36,081 · program services $29,064 · management and general $7,017
-
9 · Other employee benefits
total $71,394 · program services $70,576 · management and general $818
-
10 · Payroll taxes
total $64,307 · program services $45,845 · management and general $18,462
-
11c · Fees: accounting
total $39,067 · management and general $39,067
-
11g · Fees: other
total $211,275 · program services $211,275
-
13 · Office expenses
total $23,060 · program services $15,912 · management and general $7,148
-
14 · Information technology
total $3,230 · program services $2,755 · management and general $475
-
16 · Occupancy
total $475,040 · program services $475,040
-
17 · Travel
total $15,922 · program services $15,922
-
19 · Conferences, conventions and meetings
total $1,047 · program services $1,047
-
22 · Depreciation, depletion and amortization
total $6,185 · management and general $6,185
-
23 · Insurance
total $40,126 · management and general $40,126
-
24a · Other expenses: RESEARCH SUPPLIES
total $43,286 · program services $43,286
-
24b · Other expenses: SERVICE FEES
total $23,774 · program services $5,343 · management and general $18,431
-
24c · Other expenses: REPAIRS AND MAINTENANCE
total $21,362 · program services $21,362
-
24d · Other expenses: EQUIPMENT
total $17,232 · program services $4,376 · management and general $12,856
-
24e · All other expenses
total $12,948 · program services $11,746 · management and general $1,202
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $808,840 · end of year $765,500
-
2 · Savings and temporary cash investments
beginning of year $53,980,334 · end of year $52,661,146
-
4 · Accounts receivable
beginning of year $13,373 · end of year $28,917
-
9 · Prepaid expenses and deferred charges
beginning of year $40,889 · end of year $60,307
-
10a · Land, buildings and equipment: cost or other basis
$2,621,340
-
10b · Land, buildings and equipment: accumulated depreciation
$2,584,365
-
10c · Land, buildings and equipment, net
beginning of year $15,827 · end of year $36,975
-
11 · Investments: publicly traded securities
beginning of year $21,474,502 · end of year $30,718,309
-
12 · Investments: other securities
beginning of year $2,125,142 · end of year $1,431,471
-
14 · Intangible assets
beginning of year $12,665 · end of year $7,599
-
17 · Accounts payable and accrued expenses
beginning of year $38,323 · end of year $27,675
-
25 · Other liabilities
beginning of year $211,624 · end of year $193,657
-
27 · Net assets without donor restrictions
beginning of year $78,221,625 · end of year $85,488,892
Mission and programs · 2023
Mission
TO FIND THE CAUSE(S) OF AND BETTER PHARMACOLOGICAL TREATMENTS FOR SCHIZOPHRENIA AND BIPOLAR DISORDER.
Activities or mission (Part I)
SEE PART III, LINE 1.
-
INFECTIOUS AND NEUROVIROLOGY: SMRI IS THE MAJOR RESEARCH INSTITUTION IN THE WORLD FOCUSING ON INFECTIOUS AGENTS AS A POSSIBLE CAUSE OF SCHIZOPHRENIA AND BIPOLAR DISORDER. THE CENTER FOR THIS RESEARCH IS THE STANLEY LABORATORY OF DEVELOPMENTAL NEUROVIROLOGY AT JOHNS HOPKINS UNIVERSITY IN BALTIMORE. THIS LABORATORY WORKS CLOSELY WITH SMRI-FUNDED RESEARCHERS AT SEVERAL OTHER INSTITUTIONS. THE MAIN TARGETS OF THIS RESEARCH ARE TOXOPLASMA GONDII, THE HERPES FAMILY OF VIRUSES, AND ENDOGENOUS RETROVIRUSES.
Expenses $3,066,950 · Grants $3,030,950
-
TREATMENT TRIALS: DURING 2023, SMRI SUPPORTED 21 TRIALS FOR THE TREATMENT OF SCHIZOPHRENIA OR BIPOLAR DISORDER. MOST OF THESE WERE DRUGS THAT ARE AVAILABLE TO TREAT OTHER CONDITIONS AND FOR WHICH THERE WAS REASON TO BELIEVE THEY MIGHT ALSO BE EFFECTIVE FOR PSYCHIATRIC DISORDERS. IN ALMOST ALL CASES, PHARMACEUTICAL COMPANIES ARE UNLIKELY TO SUPPORT SUCH TRIALS BECAUSE THE DRUG IS ALREADY GENERIC OR CANNOT BE PATENTED. SMRI IS SUPPORTING MORE SUCH TREATMENT TRIALS THAN ANY OTHER ORGANIZATION IN THE WORLD.
Expenses $1,532,282 · Grants $1,471,080
-
NEUROPATHOLOGY: BRAIN TISSUE REPOSITORY AND NEUROPATHOLOGY LABORATORY: STORES AND PROCESSES POSTMORTEM BRAIN TISSUE, LIVER, SPLEEN, SERUM AND CSF FROM PEOPLE WITH SCHIZOPHRENIA, BIPOLAR DISORDER, MAJOR DEPRESSION AND FROM NORMAL CONTROL SUBJECTS. SAMPLES ARE MADE AVAILABLE TO SCIENTISTS AROUND THE WORLD. ALL RESEARCH DATA COLLECTED ON THE SPECIMENS IS RETURNED TO THE SMRI PUBLICALLY AVAILABLE WEB-BASED INTERACTIVE NEUROPATHOLOGY DATABASE FOR FURTHER ANALYSIS.
Expenses $1,521,275
-
TREATMENT ADVOCACY CENTER
Expenses $102,495 · Grants $102,495
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
MAREE J WEBSTER SEE SCHED L
EXECUTIVE DIRECTOR
- Total calculated
- $264,460
- From this org
- $224,382
- From related orgs
- $0
- Other
- $40,078
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $224,382
- Bonus
- $0
- Other
- $0
- Deferred
- $15,794
- Nontaxable benefits
- $24,284
- Filer's total
- $264,460
-
ROBERT YOLKEN SEE SCHED O
TRUSTEE
- Total calculated
- $36,000
- From this org
- $36,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 5 + 0.1 related
-
E FULLER TORREY SEE SCHED O
ASSOCIATE DIRECTOR FOR REA
- Total calculated
- $27,709
- From this org
- $24,660
- From related orgs
- $0
- Other
- $3,049
- Hours/week
- 24 + 10 related
-
STEVEN JONES
TRUSTEE
- Total calculated
- $0
- Hours/week
- 0.1
-
BARBARA TORREY
TRUSTEE
- Total calculated
- $0
- Hours/week
- 0.1 + 0.2 related
-
JONATHAN STANLEY
TRUSTEE
- Total calculated
- $0
- Hours/week
- 0.1 + 0.1 related
-
MICHAEL KNABLE SEE SCHED L
TRUSTEE
- Total calculated
- $0
- Hours/week
- 0.1 + 2 related
-
SANGHYEON KIM
ASSOC. DIR. OF DATABASE MG
- Total calculated
- $159,806
- From this org
- $110,127
- From related orgs
- $0
- Other
- $49,679
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $110,127
- Bonus
- $0
- Other
- $0
- Deferred
- $8,102
- Nontaxable benefits
- $41,577
- Filer's total
- $159,806
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
JOHNS HOPKINS UNIVERSITY - RHY
$2,525,950
NEUROVIROLOGY STUDIES-EARMARKED FOR DR.YOLKEN
-
$599,262
NEUROVIROLOGY STUDIES-EARMARKED FOR DR.DICKERSON AND TREATMENT TRIALS-EARMARKED FOR DR.DICKERSON
-
$120,794
TREATMENT TRIALS-EARMARKED FOR DR.NIMGAONKAR
-
TREATMENT TRIALS-EARMARKED FOR DR.MARDER
-
TREATMENT TRIALS-EARMARKED FOR DR.BUCHANAN
-
TREATMENT TRIALS-EARMARKED FOR DR.BROWN
-
$75,000
NEUROVIROLOGY STUDIES-EARMARKED FOR DR.FORD
-
TREATMENT TRIALS-EARMARKED FOR DR.REICHENBERG
-
TREATMENT TRIALS-EARMARKED FOR DR. VINOGRADOV
-
THE RESEARCH FOUNDATION OF SUNY
$17,390
TREATMENT TRIALS-EARMARKED FOR DR. WEICKERT
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · IMPROVE TREATMENT FOR SCHIZOPHRENIA AND BIPOLAR DISORDER · VA
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 5 July 2024
- IRS schema version
- 2023v5.1
- Source object
- 202431879349300903
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.